These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17631590)

  • 21. Role of Herceptin in primary breast cancer: views from North America and Europe.
    Leyland-Jones B; Smith I
    Oncology; 2001; 61 Suppl 2():83-91. PubMed ID: 11694792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New developments in metastatic breast cancer: general discussion.
    Vahdat LT; Rugo HS; Perez EA
    Clin Adv Hematol Oncol; 2013; 11(10 Suppl 16):16-7. PubMed ID: 24765684
    [No Abstract]   [Full Text] [Related]  

  • 23. Predicting responses to chemotherapy in breast cancer: from bench to bedside.
    Akashi-Tanaka S
    Breast Cancer; 2010 Apr; 17(2):92-6. PubMed ID: 19789951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of HER2 modulation in the adjuvant setting.
    Johnson PH; Esteva FJ
    Curr Oncol Rep; 2007 Jan; 9(1):9-16. PubMed ID: 17164042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the Preoperative Setting an Appropriate Platform for Drug Approval in Breast Cancer?
    Kaklamani VG; Gradishar WJ
    J Natl Compr Canc Netw; 2015 Nov; 13(11):1448-52. PubMed ID: 26553770
    [No Abstract]   [Full Text] [Related]  

  • 26. Adjuvant chemotherapy for early-stage breast cancer.
    McArthur HL; Hudis CA
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):207-22. PubMed ID: 17512445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Albumin-bound Paclitaxel in metastatic breast cancer: viewpoints.
    Davidson N; Ibrahim N; Harries M; Harper P
    Drugs; 2006; 66(7):949-50. PubMed ID: 16740011
    [No Abstract]   [Full Text] [Related]  

  • 28. Lurbinectedin for BRCA-mutated advanced breast cancer.
    Gourd E
    Lancet Oncol; 2018 Nov; 19(11):e582. PubMed ID: 30269906
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of microarray technology in the management of breast cancer.
    Pusztai L
    Clin Adv Hematol Oncol; 2007 Mar; 5(3):193-4, 197. PubMed ID: 17519880
    [No Abstract]   [Full Text] [Related]  

  • 30. [HER2 testing in breast cancer].
    Yoshimura K
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():275-80. PubMed ID: 17682167
    [No Abstract]   [Full Text] [Related]  

  • 31. San Antonio Breast Cancer Symposium 2016.
    Gourd K
    Lancet Oncol; 2017 Feb; 18(2):176. PubMed ID: 27989428
    [No Abstract]   [Full Text] [Related]  

  • 32. Review of recent trials of chemotherapy for advanced breast cancer: studies excluding taxanes.
    Clemons M; Leahy M; Valle J; Jayson G; Ranson M; Hayes S; Howell A
    Eur J Cancer; 1997 Nov; 33(13):2171-82. PubMed ID: 9470803
    [No Abstract]   [Full Text] [Related]  

  • 33. Anthracycline Use for Early Stage Breast Cancer in the Modern Era: a Review.
    Jasra S; Anampa J
    Curr Treat Options Oncol; 2018 May; 19(6):30. PubMed ID: 29752560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trials referral resource. Advanced breast cancer.
    Cheson BD
    Oncology (Williston Park); 1989 Jul; 3(7):113-4, 121-3. PubMed ID: 2641908
    [No Abstract]   [Full Text] [Related]  

  • 35. First MAb approved for treatment of metastatic breast cancer.
    Brenner TL; Adams VR
    J Am Pharm Assoc (Wash); 1999; 39(2):236-8. PubMed ID: 10079656
    [No Abstract]   [Full Text] [Related]  

  • 36. Relevance of tumor-infiltrating lymphocytes in breast cancer.
    Dushyanthen S; Beavis PA; Savas P; Teo ZL; Zhou C; Mansour M; Darcy PK; Loi S
    BMC Med; 2015 Aug; 13():202. PubMed ID: 26300242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of cyclin-dependent kinases 4 and 6 in breast cancer.
    Mayer EL
    Clin Adv Hematol Oncol; 2015 Apr; 13(4):215-7. PubMed ID: 26352578
    [No Abstract]   [Full Text] [Related]  

  • 38. Ribociclib in HR-positive, HER2-negative breast cancer.
    Burki TK
    Lancet Oncol; 2016 Nov; 17(11):e482. PubMed ID: 27746106
    [No Abstract]   [Full Text] [Related]  

  • 39. Next-generation targeted agents in HER2-positive metastatic breast cancer.
    Perez EA
    Clin Adv Hematol Oncol; 2012 Jul; 10(7):465-7. PubMed ID: 22895288
    [No Abstract]   [Full Text] [Related]  

  • 40. [New results of endocrine therapy of breast cancer (the role of Aromasin)].
    Semiglazov VF; Semiglazov VV; Klemtsel' AA; Barash NIu; Zhil'tsova EK; Bozhok AA; Mel'nikova OA; Paltuev RM; Dashian GA; Petrovskiĭ SG; Ivanov VG; Tonuzov EE; Berstein LM
    Vopr Onkol; 2004; 50(6):729-36. PubMed ID: 15755074
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.